Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine

Clinical Endocrinology

Volumn 70, Issue 6, 2009, Pages 932-937

  Clausen, P ^a   Mersebach, H ^a   Nielsen, B ^a   Feldt Rasmussen, B ^a   Feldt Rasmussen, U ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; LEVOTHYROXINE; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ANGIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; THYROXINE;

EID: 66149084035     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03410.x     Document Type: Article

References (29)

1. Vanhaelst, L., Neve, P., Chailly, P. et al. (1967) Coronary artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet, 2, 800 802.
2. Steinberg, A.D. (1968) Myxedema and coronary artery disease - a comparative autopsy study. Annals of Internal Medicine, 68, 338 344.
3. Hak, A.E., Pols, H.A., Visser, T.J. et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine, 132, 270 278. (Pubitemid 30106257)
4. Imaizumi, M., Akahoshi, M., Ichimaru, S. et al. (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 89, 3365 3370. (Pubitemid 38951905)
5. Biondi, B. Klein, I. (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, 24, 1 13. (Pubitemid 41364165)
6. Obuobie, K., Smith, J., Evans, L.M. et al. (2002) Increased central arterial stiffness in hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 87, 4662 4666. (Pubitemid 35247058)
7. Lekakis, J., Papamichael, C., Alevizaki, M. et al. (1997) Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid, 7, 411 414. (Pubitemid 27295140)
8. Taddei, S., Caraccio, N., Virdis, A. et al. (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism, 88, 3731 3737. (Pubitemid 37034521)
9. Ross, R. (1999) Atherosclerosis: an inflammatory disease. The New England Journal of Medicine, 340, 115 126. (Pubitemid 29054847)
10. Lip, G.Y.H. Blann, A. (1997) Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovascular Research, 34, 255 265. (Pubitemid 27241568)
11. Muller, B., Tsakiris, D.A., Roth, C.B. et al. (2001) Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation, 31, 131 137. (Pubitemid 32199906)
12. Gullu, S., Sav, H. Kamel, N. (2005) Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. European Journal of Endocrinology, 152, 355 361. (Pubitemid 40439487)
13. Monzani, F., Caraccio, N., Kozàkowà, M. et al. (2004) Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 89, 2099 2106. (Pubitemid 38619837)
14. Papaioannou, G.I., Lagasse, M., Mather, J.F. et al. (2004) Treating hypothyroidism improves endothelial function. Metabolism, 53, 278 279. (Pubitemid 38684684)
15. Nagasaki, T., Inaba, M., Henmi, Y. et al. (2004) Change in von willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy. European Journal of Endocrinology, 150, 125 131. (Pubitemid 38312804)
16. Clausen, P., Jensen, J.S., Jensen, G. et al. (2001) Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation, 103, 1869 1874. (Pubitemid 32328400)
17. Celermajer, D.S., Sorensen, K.E., Gooch, V.M. et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111 1115.
18. Joannides, R., Haefeli, W.E., Linder, L. et al. (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation, 91, 1314 1319.
19. Anderson, T.J., Uehata, A., Gerhard, M.D. et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. Journal of the American College of Cardiology, 26, 1235 1241.
20. Sorensen, K.E., Celermajer, D.S., Spiegelhalter, D.J. et al. (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. British Heart Journal, 74, 247 253.
21. Iiyama, K., Nagano, M., Yo, Y. et al. (1996) Impaired endothelial function with essential hypertension assessed by ultrasonography. American Heart Journal, 132, 779 782. (Pubitemid 26366976)
22. Duntas, L.H. (2002) Thyroid disease and lipids. Thyroid, 12, 287 293. (Pubitemid 34438931)
23. Saito, I. Saruta, T. (1994) Hypertension in thyroid disorders. Endocrinology and Metabolism Clinics of North America, 23, 379 386. (Pubitemid 24191811)
24. Thomas, G.N., Chook, P., Qiao, M. et al. (2004) Deleterious impact of 'high normal' glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 739 743. (Pubitemid 38451613)
25. Sorensen, V.R., Mathiesen, E.R., Clausen, P. et al. (2005) Impaired vascular function during short-term poor glycaemic control in type 1 diabetic patients. Diabetic Medicine, 22, 871 876. (Pubitemid 40942584)
26. Dardano, A., Ghiadoni, L., Plantinga, Y. et al. (2006) Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 91, 4175 4178. (Pubitemid 44536902)
27. Xiang, G.-D., He, Y.-S., Zhao, L.-S. et al. (2006) Impairment of endothelium-dependent arterial dilation in Hashimoto's thyroiditis patients with euthyroidism. Clinical Endocrinology, 64, 698 702. (Pubitemid 43775010)
28. Taddei, S., Caraccio, N., Virdis, A. et al. (2006) Low-grade systemic inflammation causes endothelial dysfunction in patients with Hasimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism, 91, 5076 5082.
29. Perk, M. O'Neill, B.J. (1997) The effect of thyroid hormone therapy on angiographic coronary artery disease progression. The Canadian Journal of Cardiology, 13, 273 276. (Pubitemid 27156518)